Liver News and Research

RSS

Head injuries, traumatic experiences and mental illness higher among severe polyinhalant users

Incarcerated youth who have suffered head injuries, traumatic experiences and mental illness diagnoses are more likely to abuse multiple inhalants, according to researchers at Georgia State University and the University of North Carolina at Chapel Hill.

14 Oct 2015

European liver patients’ association launches call to action report for the treatment of heapatic encephalopathy

ELPA today launched a new call to action report ‘Time to DeLiver: Getting a Grip on HE’ at the European Parliament in Brussels. This is the first report from Europe to highlight the significant burden of hepatic encephalopathy on patients, their carers, families and society.

14 Oct 2015

Lilly, ImaginAb partner to study potential novel T-cell-based immuno-oncology therapies

Eli Lilly and Company and ImaginAb Inc. are pleased to announce a preclinical research collaboration to study potential novel T-cell-based immuno-oncology therapies.

13 Oct 2015

Men on effective HIV therapy less likely to get HBV infection, shows research

Previous studies of individuals with HIV have suggested that HIV drug regimens that included drugs active against hepatitis B virus (HBV) can decrease the risk of infection with the liver-damaging HBV.

13 Oct 2015

Can-Fite's CF102 granted Orphan Drug Designation by EMA for treatment of hepatocellular carcinoma

Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, today announced the Company's oncology drug candidate, CF102, has been granted Orphan Drug Designation by the European Medicines Agency (EMA) for the indication of hepatocellular carcinoma (HCC), the most common form of liver cancer.

12 Oct 2015

QMUL, UCT researchers awarded £3.5m MRC grant to prevent TB in South African primary school children

The Medical Research Council has awarded a grant of £3.5m to researchers from Queen Mary University of London and University of Cape Town to carry out a trial to determine whether a weekly vitamin D supplement can prevent tuberculosis (TB) in South African primary school children.

12 Oct 2015

Study looks at survival benefits of surgical resection for melanoma patients with abdominal metastases

Patients with metastatic melanoma who undergo surgery to remove lesions that have spread into the abdomen live more than twice as long as those treated with drug therapy alone, according to novel new research by a North Shore-LIJ Health System cancer surgeon.

12 Oct 2015

FDA approves Opdivo to treat patients with advanced non-small cell lung cancer

The U.S. Food and Drug Administration today approved Opdivo (nivolumab) to treat patients with advanced (metastatic) non-small cell lung cancer whose disease progressed during or after platinum-based chemotherapy.

11 Oct 2015

Scientists can now use skin samples from older patients to grow brain cells

For the first time, scientists can use skin samples from older patients to create brain cells without rolling back the youthfulness clock in the cells first. The new technique, which yields cells resembling those found in older people's brains, will be a boon to scientists studying age-related diseases like Alzheimer's and Parkinson's.

9 Oct 2015

FDA approves Promacta to treat pediatric patients with chronic immune thrombocytopenic purpura

The U.S. Food and Drug Administration today approved Promacta (eltrombopag) to treat low blood platelet count in pediatric patients – ages one year and older – with a rare blood disorder called chronic immune thrombocytopenic purpura (ITP). Promacta can be used in these children when they have not achieved an appropriate response using other ITP medicines or surgery to remove the spleen.

9 Oct 2015

Light-chain amyloidosis patients treated with high-dose chemo and stem cell transplantation have long-term survival

Patients with Light-chain (AL) amyloidosis who are treated with high-dose chemotherapy (melphalan) and autologous (one's own) stem cell transplantation (HDM/SCT) have the greatest success for long-term survival.

9 Oct 2015

Repatha (evolocumab) injection gets FDA approval for high cholesterol

The U.S. Food and Drug Administration today approved Repatha (evolocumab) injection for some patients who are unable to get their low-density lipoprotein (LDL) cholesterol under control with current treatment options.

9 Oct 2015

Immunovia and OHSU team up to validate, commercialize blood test for early diagnosis of pancreatic cancer

Immunovia AB and the Knight Cancer Institute at Oregon Health & Science University formed a collaboration to confirm, validate and commercialize a blood test for the early diagnosis of pancreatic cancer. The test called IMMray™ PanCan-d analyses a patient's immune system for early signs of disease. The collaboration will also enable researchers to explore biomarkers for a number of other cancer types.

9 Oct 2015

EMA completes review of proposed amendment to OncoGenex's Phase 3 AFFINITY trial protocol

OncoGenex Pharmaceuticals, Inc. announced today that the European Medicines Agency has completed its review of the proposed amendment to the company's Phase 3 AFFINITY protocol and statistical analysis plan.

8 Oct 2015

New research highlights vitamin E needs for people with metabolic syndrome

New research shows that the estimated one-third of Americans who have a cluster of health problems that add up to metabolic syndrome don't absorb dietary vitamin E as effectively as healthy people.

8 Oct 2015

New report reveals more about how stem cells are affected by immediate surroundings

A Johns Hopkins University biologist has led a research team reporting progress in understanding the mysterious shape-shifting ways of stem cells, which have vast potential for medical research and disease treatment.

8 Oct 2015

New diagnostic technology based on computer algorithms can quickly identify source of cancer

In by far the majority of cancer cases, the doctor can quickly identify the source of the disease, for example cancer of the liver, lungs, etc. However, in about one in 20 cases, the doctor can confirm that the patient has cancer—but cannot find the source. These patients then face the prospect of a long wait with numerous diagnostic tests and attempts to locate the origin of the cancer before starting any treatment.

7 Oct 2015

Nurses who work with organ transplant patients experience high levels of emotional exhaustion

More than half of nurses who work with organ transplant patients in the United States experience high levels of emotional exhaustion, a primary sign of burnout, according to a study published by researchers at Henry Ford Hospital.

7 Oct 2015

Acetaminophen Awareness Coalition issues safety message to consumers about flu medicines

With cold and flu season around the corner, consumers will soon begin to purchase medicines such as cough syrup, throat lozenges, and nasal sprays to help get relief from symptoms such as fever, coughs, congestion, and more. Many of the medicines used to treat these cold and flu symptoms can contain common drug ingredients such as acetaminophen.

6 Oct 2015

Mercy open new Endoscopy Suite to promote and practice gastrointestinal health

Mercy Medical Center has announced the opening of a new, state-of-the-art Endoscopy Suite to promote and practice gastrointestinal health. The unique, high-tech suite is located on the 2nd floor of Mercy's Mary Catherine Bunting Center at 345 St. Paul Place. Bunting Endoscopy will be under the direction of Dr. Paul J. Thuluvath, Medical Director of The Melissa L. Posner Institute for Digestive Health & Liver Disease at Mercy.

6 Oct 2015

Liver News and Research

Head injuries, traumatic experiences and mental illness higher among severe polyinhalant users

European liver patients’ association launches call to action report for the treatment of heapatic encephalopathy

Lilly, ImaginAb partner to study potential novel T-cell-based immuno-oncology therapies

Men on effective HIV therapy less likely to get HBV infection, shows research

Can-Fite's CF102 granted Orphan Drug Designation by EMA for treatment of hepatocellular carcinoma

QMUL, UCT researchers awarded £3.5m MRC grant to prevent TB in South African primary school children

Study looks at survival benefits of surgical resection for melanoma patients with abdominal metastases

FDA approves Opdivo to treat patients with advanced non-small cell lung cancer

Scientists can now use skin samples from older patients to grow brain cells

FDA approves Promacta to treat pediatric patients with chronic immune thrombocytopenic purpura

Light-chain amyloidosis patients treated with high-dose chemo and stem cell transplantation have long-term survival

Repatha (evolocumab) injection gets FDA approval for high cholesterol

Immunovia and OHSU team up to validate, commercialize blood test for early diagnosis of pancreatic cancer

EMA completes review of proposed amendment to OncoGenex's Phase 3 AFFINITY trial protocol

New research highlights vitamin E needs for people with metabolic syndrome

New report reveals more about how stem cells are affected by immediate surroundings

New diagnostic technology based on computer algorithms can quickly identify source of cancer

Nurses who work with organ transplant patients experience high levels of emotional exhaustion

Acetaminophen Awareness Coalition issues safety message to consumers about flu medicines

Mercy open new Endoscopy Suite to promote and practice gastrointestinal health

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News